ACUR.US Acura Pharmaceuticals Inc

Healthcare Pharmaceuticals USA Stocks
0.0003 USD
Close of Nov 12, 2026
0.0001 0.0100
Market cap
USD 19.8K
P/E
-
P/B
24.11x
ROE
-493.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2021.

Is ACUR.US undervalued?

Graham number

The Graham number of Acura Pharmaceuticals Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Acura Pharmaceuticals Inc fundamental analysis

No fundamental analysis for Acura Pharmaceuticals Inc yet.

Acura Pharmaceuticals Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Acura Pharmaceuticals Inc

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and …

Full company profile